Transitioning from "Dr. Google" to "Dr. ChatGPT": the advent of artificial intelligence chatbots

doi:10.21037/tau-23-629

Editorial

. 2024 Jun 30;13(6):1067-1070.

doi: 10.21037/tau-23-629. Epub 2024 May 23.

Transitioning from "Dr. Google" to "Dr. ChatGPT": the advent of artificial intelligence chatbots

Enrico Checcucci¹, Severin Rodler^{2

3

4}, Pietro Piazza⁵, Francesco Porpiglia⁶, Giovanni Enrico Cacciamani^{2

3}

Affiliations

¹ Department of Surgery, Candiolo Cancer Institute (FPO-IRCCS), Candiolo, Italy.
² Catherine and Joseph Aresty Department of Urology, Keck School of Medicine, USC Institute of Urology, Los Angeles, CA, USA.
³ Artificial Intelligence Center at USC Institute of Urology, Los Angeles, CA, USA.
⁴ Department of Urology, University Hospital of Munich (LMU), Munich, Germany.
⁵ Division of Urology, IRCCS Azienda Ospedaliero- Universitaria di Bologna, Bologna, Italy.
⁶ Department of Oncology, Division of Urology, University of Turin, San Luigi Gonzaga Hospital, Orbassano, TO, Italy.

PMID: 38983463
PMCID: PMC11228672
DOI: 10.21037/tau-23-629

Editorial

Transitioning from "Dr. Google" to "Dr. ChatGPT": the advent of artificial intelligence chatbots

Enrico Checcucci et al. Transl Androl Urol. 2024.

. 2024 Jun 30;13(6):1067-1070.

doi: 10.21037/tau-23-629. Epub 2024 May 23.

Authors

Enrico Checcucci¹, Severin Rodler^{2

3

4}, Pietro Piazza⁵, Francesco Porpiglia⁶, Giovanni Enrico Cacciamani^{2

3}

Affiliations

¹ Department of Surgery, Candiolo Cancer Institute (FPO-IRCCS), Candiolo, Italy.
² Catherine and Joseph Aresty Department of Urology, Keck School of Medicine, USC Institute of Urology, Los Angeles, CA, USA.
³ Artificial Intelligence Center at USC Institute of Urology, Los Angeles, CA, USA.
⁴ Department of Urology, University Hospital of Munich (LMU), Munich, Germany.
⁵ Division of Urology, IRCCS Azienda Ospedaliero- Universitaria di Bologna, Bologna, Italy.
⁶ Department of Oncology, Division of Urology, University of Turin, San Luigi Gonzaga Hospital, Orbassano, TO, Italy.

PMID: 38983463
PMCID: PMC11228672
DOI: 10.21037/tau-23-629

No abstract available

Keywords: Artificial intelligence (AI); Dr. ChatGPT; Dr. Google; large language model (LLM).

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://tau.amegroups.com/article/view/10.21037/tau-23-629/coif). S.R. receives consultancy fees from Merck, MSD and Novartis and has equity in Rocketlane Medical Ventures GmbH. The other authors have no conflicts of interest to declare.

Comment on

How Well Do Artificial Intelligence Chatbots Respond to the Top Search Queries About Urological Malignancies?
Musheyev D, Pan A, Loeb S, Kabarriti AE. Musheyev D, et al. Eur Urol. 2024 Jan;85(1):13-16. doi: 10.1016/j.eururo.2023.07.004. Epub 2023 Aug 10. Eur Urol. 2024. PMID: 37567827

Cited by

Comparative analysis of the effectiveness of microsoft copilot artificial intelligence chatbot and google search in answering patient inquiries about infertility: evaluating readability, understandability, and actionability.
Bahçeci T, Elmaağaç B, Ceyhan E. Bahçeci T, et al. Int J Impot Res. 2025 Apr 22. doi: 10.1038/s41443-025-01056-z. Online ahead of print. Int J Impot Res. 2025. PMID: 40263578
Physician vs. AI-generated messages in urology: evaluation of accuracy, completeness, and preference by patients and physicians.
Robinson EJ, Qiu C, Sands S, Khan M, Vora S, Oshima K, Nguyen K, DiFronzo LA, Rhew D, Feng MI. Robinson EJ, et al. World J Urol. 2024 Dec 27;43(1):48. doi: 10.1007/s00345-024-05399-y. World J Urol. 2024. PMID: 39729119 Free PMC article.
[Digital urology : Possible uses for artificial intelligence and digital health applications].
Rinderknecht E, Alexa R, Carl N, Goertz M, Wessels F, Borgmann H. Rinderknecht E, et al. Urologie. 2025 Jul 14. doi: 10.1007/s00120-025-02651-0. Online ahead of print. Urologie. 2025. PMID: 40659882 Review. German.

References

1. Cacciamani GE, Bassi S, Sebben M, et al. Consulting "Dr. Google" for Prostate Cancer Treatment Options: A Contemporary Worldwide Trend Analysis. Eur Urol Oncol 2020;3:481-8. 10.1016/j.euo.2019.07.002 - DOI - PMC - PubMed
1. Cacciamani GE, Dell'Oglio P, Cocci A, et al. Asking "Dr. Google" for a Second Opinion: The Devil Is in the Details. Eur Urol Focus 2021;7:479-81. 10.1016/j.euf.2019.10.011 - DOI - PubMed
1. Porpiglia F, Amparore D, Checcucci E, et al. The revolution of congress meetings and scientific events: how to navigate among their heterogeneous modalities? Minerva Urol Nephrol 2021;73:3-5. 10.23736/S2724-6051.20.04177-6 - DOI - PubMed
1. Amparore D, Campi R, Checcucci E, et al. Patients' perspective on the use of telemedicine for outpatient urological visits: Learning from the COVID-19 outbreak. Actas Urol Esp (Engl Ed) 2020;44:637-8. 10.1016/j.acuroe.2020.06.002 - DOI - PMC - PubMed
1. Wang S, Malik RD. Social Media and Apps in Urology. Curr Surg Rep 2023. [Epub ahead of print]. doi: .10.1007/s40137-023-00366-9 - DOI - PMC - PubMed

Publication types

Actions
Actions

LinkOut - more resources

Full Text Sources

[1] Cacciamani GE, Bassi S, Sebben M, et al. Consulting "Dr. Google" for Prostate Cancer Treatment Options: A Contemporary Worldwide Trend Analysis. Eur Urol Oncol 2020;3:481-8. 10.1016/j.euo.2019.07.002 - DOI - PMC - PubMed

[2] Cacciamani GE, Bassi S, Sebben M, et al. Consulting "Dr. Google" for Prostate Cancer Treatment Options: A Contemporary Worldwide Trend Analysis. Eur Urol Oncol 2020;3:481-8. 10.1016/j.euo.2019.07.002 - DOI - PMC - PubMed

[3] Cacciamani GE, Dell'Oglio P, Cocci A, et al. Asking "Dr. Google" for a Second Opinion: The Devil Is in the Details. Eur Urol Focus 2021;7:479-81. 10.1016/j.euf.2019.10.011 - DOI - PubMed

[4] Cacciamani GE, Dell'Oglio P, Cocci A, et al. Asking "Dr. Google" for a Second Opinion: The Devil Is in the Details. Eur Urol Focus 2021;7:479-81. 10.1016/j.euf.2019.10.011 - DOI - PubMed

[5] Porpiglia F, Amparore D, Checcucci E, et al. The revolution of congress meetings and scientific events: how to navigate among their heterogeneous modalities? Minerva Urol Nephrol 2021;73:3-5. 10.23736/S2724-6051.20.04177-6 - DOI - PubMed

[6] Porpiglia F, Amparore D, Checcucci E, et al. The revolution of congress meetings and scientific events: how to navigate among their heterogeneous modalities? Minerva Urol Nephrol 2021;73:3-5. 10.23736/S2724-6051.20.04177-6 - DOI - PubMed

[7] Amparore D, Campi R, Checcucci E, et al. Patients' perspective on the use of telemedicine for outpatient urological visits: Learning from the COVID-19 outbreak. Actas Urol Esp (Engl Ed) 2020;44:637-8. 10.1016/j.acuroe.2020.06.002 - DOI - PMC - PubMed

[8] Amparore D, Campi R, Checcucci E, et al. Patients' perspective on the use of telemedicine for outpatient urological visits: Learning from the COVID-19 outbreak. Actas Urol Esp (Engl Ed) 2020;44:637-8. 10.1016/j.acuroe.2020.06.002 - DOI - PMC - PubMed

[9] Wang S, Malik RD. Social Media and Apps in Urology. Curr Surg Rep 2023. [Epub ahead of print]. doi: .10.1007/s40137-023-00366-9 - DOI - PMC - PubMed

[10] Wang S, Malik RD. Social Media and Apps in Urology. Curr Surg Rep 2023. [Epub ahead of print]. doi: .10.1007/s40137-023-00366-9 - DOI - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Transitioning from "Dr. Google" to "Dr. ChatGPT": the advent of artificial intelligence chatbots

Affiliations

Transitioning from "Dr. Google" to "Dr. ChatGPT": the advent of artificial intelligence chatbots

Authors

Affiliations

Conflict of interest statement

Comment on

Similar articles

Cited by

References

Publication types

LinkOut - more resources

Full Text Sources